Daisuke Takahashi

Dr. Daisuke Takahashi


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MTMohamad Alaa Terkawi
Mohamad Alaa Terkawi
GMGen Matsumae
Gen Matsumae
TSTomohiro Shimizu
Tomohiro Shimizu
DTDaisuke Takahashi
Daisuke Takahashi
KKKen Kadoya
Ken Kadoya
NINorimasa Iwasaki
Norimasa Iwasaki
Bone is a mineralized and elastic connective tissue that provides fundamental functions in the human body, including mechanical support to the muscles and joints, protection of vital organs and storage of minerals. Bone is a metabolically active organ that undergoes continuous remodeling processes to maintain its architecture, shape, and function throughout life. One of the most important medical discoveries of recent decades has been that the immune system is involved in bone remodeling. Indeed, chronic inflammation has been recognized as the most significant factor influencing bone homeostasis, causing a shift in the bone remodeling process toward pathological bone resorption. Bone osteolytic diseases typified by excessive bone resorption account for one of the greatest causes of disability worldwide, with significant economic and public health burdens. From this perspective, we discuss the recent findings and discoveries highlighting the cellular and molecular mechanisms that regulate this process in the bone microenvironment, in addition to the current therapeutic strategies for the treatment of osteolytic bone diseases.

10 May 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
MTMohamad Alaa Terkawi
Mohamad Alaa Terkawi
TETaku Ebata
Taku Ebata
SYShunichi Yokota
Shunichi Yokota
DTDaisuke Takahashi
Daisuke Takahashi
TETSUTOMU ENDO
TSUTOMU ENDO
NINorimasa Iwasaki
Norimasa Iwasaki
Osteoarthritis (OA) is a musculoskeletal disease characterized by cartilage degeneration and stiffness, with chronic pain in the affected joint. It has been proposed that OA progression is associated with the development of low-grade inflammation (LGI) in the joint. In support of this principle, LGI is now recognized as the major contributor to the pathogenesis of obesity, aging, and metabolic syndromes, which have been documented as among the most significant risk factors for developing OA. These discoveries have led to a new definition of the disease, and OA has recently been recognized as a low-grade inflammatory disease of the joint. Damage-associated molecular patterns (DAMPs)/alarmin molecules, the major cellular components that facilitate the interplay between cells in the cartilage and synovium, activate various molecular pathways involved in the initiation and maintenance of LGI in the joint, which, in turn, drives OA progression. A better understanding of the pathological mechanisms initiated by LGI in the joint represents a decisive step toward discovering therapeutic strategies for the treatment of OA. Recent findings and discoveries regarding the involvement of LGI mediated by DAMPs in OA pathogenesis are discussed. Modulating communication between cells in the joint to decrease inflammation represents an attractive approach for the treatment of OA.

11 April 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
SYShunichi Yokota
Shunichi Yokota
HIHotaka Ishizu
Hotaka Ishizu
TMTakuji Miyazaki
Takuji Miyazaki
DTDaisuke Takahashi
Daisuke Takahashi
NINorimasa Iwasaki
Norimasa Iwasaki
TSTomohiro Shimizu
Tomohiro Shimizu
The increased incidence of osteoarthritis (OA), particularly knee and hip OA, and osteoporosis (OP), owing to population aging, have escalated the medical expense burden. Osteoarthritis is more prevalent in older women, and the involvement of subchondral bone fragility spotlights its association with OP. Notably, subchondral insufficiency fracture (SIF) may represent a more pronounced condition of OA pathophysiology. This review summarizes the relationship between OA and OP, incorporating recent insights into SIF. Progressive SIF leads to joint collapse and secondary OA and is associated with OP. Furthermore, the thinning and fragility of subchondral bone in early-stage OA suggest that SIF may be a subtype of OA (osteoporosis-related OA, OPOA) characterized by significant subchondral bone damage. The high bone mineral density observed in OA may be overestimated due to osteophytes and sclerosis and can potentially contribute to OPOA. The incidence of OPOA is expected to increase along with population aging. Therefore, prioritizing OP screening, early interventions for patients with early-stage OA, and fracture prevention measures such as rehabilitation, fracture liaison services, nutritional management, and medication guidance are essential.

16 April 2024 in Journal of Bone and Joint Surgery
Verified
Journal Article
Open access
TSTaishi Sato
Taishi Sato
SYSatoshi Yamate
Satoshi Yamate
TUTakeshi Utsunomiya
Takeshi Utsunomiya
YIYutaka Inaba
Yutaka Inaba
HIHiroyuki Ike
Hiroyuki Ike
TCthe Japanese Hip OA Consortium
the Japanese Hip OA Consortium
Background: The incidence of developmental dysplasia of the hip (DDH) in Japanese newborns has reduced drastically following a primary prevention campaign initiated around 1972 to 1973; this perinatal education campaign promoted maintaining the hips of newborns in the naturally flexed-leg position. The purpose of the present study was to describe the life course epidemiology of hip osteoarthritis (OA) in adolescent and adult patients and to assess its association with exposure to the primary prevention campaign for DDH. Methods: We included new patients with hip OA diagnosed from January 1, 2022, to December 31, 2022, at 12 core hospitals (8 special-function hospitals and 4 regional medical care support hospitals). The trend in the percentage of hips with a history of DDH treatment in childhood was estimated with use of a centered moving average using the birth year of the patient. We compared the prevalence of severe subluxation (Crowe type II, III, or IV) between patients with secondary hip OA due to hip dysplasia who were born in or before 1972 and those who were born in or after 1973. Results: Overall, 1,095 patients (1,381 hips) were included. The mean age at the time of the survey was 63.5 years (range, 15 to 95 years). A total of 795 patients (1,019 hips; 73.8% of hips) were diagnosed with secondary OA due to hip dysplasia. Approximately 13% to 15% of hips among patients born from 1963 to 1972 had a history of DDH treatment in childhood; however, the percentage decreased among patients born in or after 1973. The prevalence of severe subluxation (Crowe type II, III, or IV) among patients born in or after 1973 was 2.4%, which was significantly less than that among patients born in or before 1972 (11.1%; odds ratio, 0.20; p < 0.001). Conclusions: As of 2022, secondary hip OA due to hip dysplasia is still responsible for most new cases of adolescent and adult hip OA seen in core hospitals in Japan. However, the perinatal education campaign initiated 50 years ago, which utilized a population approach and advocated for maintaining the hips of newborns in the naturally flexed-leg position, may have improved the environmental factors of DDH, as indicated by the apparently reduced need for treatment of DDH in childhood and the associated severe subluxation. This may result in a reduced need for challenging hip surgery later in life. Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

8 November 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YSYuma Sakamoto
Yuma Sakamoto
TYTakuaki Yamamoto
Takuaki Yamamoto
NSNobuhiko Sugano
Nobuhiko Sugano
DTDaisuke Takahashi
Daisuke Takahashi
TWToshiyuki Watanabe
Toshiyuki Watanabe
SIShiro Ikegawa
Shiro Ikegawa
Idiopathic osteonecrosis of the femoral head (IONFH) is an ischemic disorder that causes bone necrosis of the femoral head, resulting in hip joint dysfunction. IONFH is a polygenic disease and steroid and alcohol have already known to increase its risk; however, the mechanism of IONFH remains to be elucidated. We performed a genome-wide association study using ~60,000 subjects and found two novel loci on chromosome 20q12 and 12q24. Big data analyses identified LINC01370 as a candidate susceptibility gene in the 20q12 locus. Stratified analysis by IONFH risk factors suggested that the 12q24 locus was associated with IONFH through drinking capacity. Our findings would shed new light on pathophysiology of IONFH.

1 April 2019 in Acta Biomaterialia
Verified
Journal Article
Closed access
MTMohamad Alaa Terkawi
Mohamad Alaa Terkawi
KKKen Kadoya
Ken Kadoya
DTDaisuke Takahashi
Daisuke Takahashi
YTYuan Tian
Yuan Tian
MHMasanari Hamasaki
Masanari Hamasaki
NINorimasa Iwasaki
Norimasa Iwasaki